RESUMEN
Milk-derived bioactive peptides with a single activity (e.g., antioxidant, immunomodulatory, or antimicrobial) have been previously well documented; however, few studies describe multifunctional bioactive peptides, which may be preferred over single-activity peptides, as they can simultaneously trigger, modulate, or inhibit multiple physiological pathways. Hence, the aim of this study was to assess the anti-inflammatory, antihemolytic, antioxidant, antimutagenic, and antimicrobial activities of crude extracts (CE) and peptide fractions (<3 and 3-10 kDa) obtained from fermented milks with specific Lactobacillus plantarum strains. Overall, CE showed higher activity than both peptide fractions (<3 and 3-10 kDa) in most of the activities assessed. Furthermore, activity of <3 kDa was generally higher, or at least equal, to the 3 to 10 kDa peptide fractions. In particular, L. plantarum 55 crude extract or their fractions showed the higher anti-inflammatory (723.68-1,759.43µg/mL of diclofenac sodium equivalents), antihemolytic (36.65-74.45% of inhibition), and antioxidant activity [282.8-362.3µmol of Trolox (Sigma-Aldrich, St. Louis, MO) equivalents]. These results provide valuable evidence of multifunctional role of peptides derived of fermented milk by the action of specific L. plantarum strains. Thus, they may be considered for the development of biotechnological products to be used to reduce the risk of disease or to enhance a certain physiological function.
Asunto(s)
Productos Lácteos Cultivados/análisis , Lactobacillus plantarum/fisiología , Péptidos/análisis , Animales , Antiinfecciosos/análisis , Antiinflamatorios/análisis , Antimutagênicos/análisis , Antioxidantes/análisis , Fermentación , Lactobacillus plantarum/genética , Leche/química , Proteínas de la Leche/análisisRESUMEN
In this study we optimized an enzyme-linked immunosorbent assay (ELISA) to evaluate bothropic venom levels in biological samples. These samples were obtained by two distinct protocols. In the first one, Swiss mice were injected with 1 LD50 of Bothrops jararaca (B. jararaca) venom and 15 minutes later, animals were treated with ovine antibothropic serum. Blood and spleen homogenate samples were obtained 6 hours after antiserum therapy. Ovine antibothropic serum significantly neutralized venom levels in serum and spleen. In the second protocol, BALB/c mice were injected with 1 LD50 of bothropic venom by either intraperitoneal (IP) or intradermal (ID) route and venom levels were evaluated 1, 3 and 6 hours after, in blood, spleen homogenates and urine. Serum and splenic venom levels were significantly higher in animals envenomed by IP route comparing with animals envenomed by ID route. Higher venom levels were also detected in urine samples from animals envenomed by IP route. However, these differences were not statistically significant. These results demonstrated that the optimized ELISA was adequate to quantify venom levels in different biological samples. This assay could, therefore, substitute the in vivo neutralizing assay and also be useful to evaluate the severity of human and experimental envenomations.
Asunto(s)
Ratas , Animales , Masculino , Femenino , Antivenenos , Bothrops/inmunología , Sueros Inmunes , Ovinos , Venenos de Crotálidos/inmunología , ConejosRESUMEN
Alternative sources of anti-ophidic serum are being investigated due to the secondary effects associated with types I and II hypersensitivity reactions. In the present study we raised and evaluated the protective effect of an ovine antibothropic serum in a Swiss mice envenoming model. Ovine antiserum was obtained by immunization with seven increasing doses of bothropic venom associated with adjuvants. The neutralizing ability was tested by the lethal activity (2 LD50) neutralization and serum and splenic venom levels after antivenom administration to experimentally envenomed mice. The antiserum effect on local edema was also tested by injection of venom/antivenom mixtures into the mice footpads. Ovine antiserum neutralized lethal activity and also significantly decreased serum and splenic venom levels. However, this antiserum was not able to mediate any protective effect on edema triggered by bothropic venom
Asunto(s)
Animales , Masculino , Femenino , Ratones , Conejos , Antivenenos , Bothrops , Venenos de Crotálidos , Ratones , Ovinos , Pruebas de NeutralizaciónRESUMEN
Recent work demonstrated that crotoxin, the main toxin of Crotalus durissus terrificus venom, inhibits macrophage spreading and phagocytic activities. The crotoxin molecule is composed of two subunits, an acidic non-toxic and non-enzymatic polypeptide named crotapotin and a weakly toxic basic phospholipase A(2) (PLA(2)). In the present work, the active subunit responsible for the inhibitory effect of crotoxin on macrophage function was investigated. Peritoneal macrophages harvested from naive rats were used. Crotapotin (2.12, 3.75, or 8.37nM/ml), added for 2h to the medium of peritoneal cell incubation, did not modify the spreading and phagocytic activities of these cells. On the other hand, the PLA(2) (1.43, 2.86, or 6.43nM/ml) subunit caused a significant reduction (30, 33, and 35%, respectively) of the spreading activity. The PLA(2) also inhibited the phagocytosis of opsonised zymosan, opsonised sheep erythrocytes, and Candida albicans, indicating that this inhibitory effect is not dependent on the type of receptor involved in the phagocytosis process. The inhibitory effect of PLA(2) was not due to loss of cell membrane integrity, since macrophage viability was higher than 95%. These findings indicate that the inhibitory effect of crotoxin on macrophage spreading and phagocytic activities is caused by the phospholipase A(2) subunit.
Asunto(s)
Venenos de Crotálidos/enzimología , Crotalus , Macrófagos/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Fosfolipasas A/toxicidad , Análisis de Varianza , Animales , Candida albicans/metabolismo , Relación Dosis-Respuesta a Droga , Eritrocitos/metabolismo , Masculino , Ratas , Ratas Wistar , Ovinos , Zimosan/metabolismoRESUMEN
Our previous studies have shown that [(14)C]-labelled cholesterol (CHOL) and arachidonic acid (AA) are transferred from macrophages (Mphi) to lymphocytes (LY) when these cells are co-cultured. In this study, we investigated whether these lipids can be transferred from control and thioglycollate-elicited Mphi (THIO-elicited Mphi) to various tissues and organs in vivo. For this purpose, control and THIO-elicited Mphi were pre-treated with [(14)C]-AA and [(3)H]-CHOL and then injected into the jugular vein of adult rats. More than 75% of the radioactivity injected was found in the liver of rats treated with [(14)C]-AA labelled-Mphi either control and THIO-stimulated. The radioactivity of [(3)H]-CHOL labelled Mphi was transferred mainly to the liver (51% in the control Mphi and 23% in the thioglycollate Mphi7) but it was also found in the kidney, lung and spleen. These results support the proposition that the transfer of lipids between cells also occurs in vivo. The full significance of this phenomenon however remains to be elucidated.
Asunto(s)
Ácido Araquidónico/metabolismo , Colesterol/metabolismo , Macrófagos/metabolismo , Envejecimiento , Animales , Transporte Biológico , Masculino , Ratas , Ratas Wistar , Tioglicolatos/metabolismoRESUMEN
The incorporation and oxidation of arachidonic acid (AA) by rat lymphocytes (LY), the transfer of AA from LY to rat macrophages (Mphi) in co-culture, and the subsequent functional impact on Mphi phagocytosis were investigated. The rate of incorporation of [1-14C]AA by untreated-LY and TG (thioglycolate treated)-LY (TG-LY) was 158 +/- 8 nmol/10(10) LY per h for both untreated-LY and TG-LY. The oxidation of AA was 3.4-fold higher in TG-LY as compared with untreated cells. LY from TG-injected rats had a 2.5-fold increase in the oxidation of palmitic (PA), oleic (OA), and linoleic (LA) acids. After 6 h of incubation, [14C] from AA was distributed mainly into phospholipids. The rate of incorporation into total lipids was 1071 nmol/10(10) cells in untreated-LY and 636 nmol/10(10) cells in TG-LY. [14C]AA was transferred from LY to co-cultured Mphi in substantial amounts (8.7 nmol for untreated and 15 nmol per 10(10) for TG cells). Exogenously added AA, PA, OA, and LA caused a significant reduction of phagocytosis by resident cells. Mphi co-cultured with AA-preloaded LY showed a significant reduction of the phagocytic capacity (about 40% at 35 microM). LY preloaded with PA, LA, and OA also induced a reduction in phagocytic capacity of co-cultured Mphi. TG treatment abolished the AA-induced inhibition of phagocytosis in Mphi co-cultured with TG-LY. Therefore, the transfer of AA between leukocytes is a modulated process and may play an important role in controlling inflammatory and immune response.
Asunto(s)
Ácido Araquidónico/metabolismo , Linfocitos/metabolismo , Macrófagos/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Isótopos de Carbono , Células Cultivadas , Cromatografía en Capa Delgada , Técnicas de Cocultivo , Metabolismo de los Lípidos , Linfocitos/citología , Linfocitos/efectos de los fármacos , Macrófagos/citología , Macrófagos/efectos de los fármacos , Ratas , Tioglicolatos/farmacologíaRESUMEN
The incorporation and oxidation of arachidonic acid (AA) by rat lymphocytes (LY), the transfer of AA from LY to rat macrophages (Mö) in co-culture, and the subsequent functional impact on Mö phagocytosis were investigated. The rate of incorporation of [1-14C]AA by untreated-LY and TG (thioglycolate treated)-LY (TG-LY) was 158 ± 8 nmol/1010 LY per h for both untreated-LY and TG-LY. The oxidation of AA was 3.4-fold higher in TG-LY as compared with untreated cells. LY from TG-injected rats had a 2.5-fold increase in the oxidation of palmitic (PA), oleic (OA), and linoleic (LA) acids. After 6 h of incubation, [14C] from AA was distributed mainly into phospholipids. The rate of incorporation into total lipids was 1071 nmol/1010 cells in untreated-LY and 636 nmol/1010 cells in TG-LY. [14C]AA was transferred from LY to co-cultured Mö in substantial amounts (8.7 nmol for untreated and 15 nmol per 1010 for TG cells). Exogenously added AA, PA, OA, and LA caused a significant reduction of phagocytosis by resident cells. Mö co-cultured with AA-preloaded LY showed a significant reduction of the phagocytic capacity (about 40% at 35 ìM). LY preloaded with PA, LA, and OA also induced a reduction in phagocytic capacity of co-cultured Mö. TG treatment abolished the AA-induced inhibition of phagocytosis in Mö co-cultured with TG-LY. Therefore, the transfer of AA between leukocytes is a modulated process and may play an important role in controlling inflammatory and immune response.
Asunto(s)
Animales , Linfocitos , Ácido AraquidónicoRESUMEN
The transport of palmitic acid (PA) across planar lipid bilayer membranes was measured using a high specific activity [14C]palmitate as tracer for PA. An all-glass trans chamber was employed in order to minimize adsorbance of PA onto the surface. Electrically neutral (diphytanoyl phosphatidylcholine) and charged (Azolectin) planar bilayers were maintained at open electric circuit. We found a permeability to PA of (8.8 +/- 1.9) x 10(-6) cm s(-1) (n = 15) in neutral and of (10.3 +/- 2.2) x 10(-6) cm s(-1) (n = 5) in charged bilayers. These values fall within the order of magnitude of those calculated from desorption constants of PA in different vesicular systems. Differences between data obtained from planar and vesicular systems are discussed in terms of the role of solvent, radius of curvature, and pH changes.
Asunto(s)
Ácidos Grasos/metabolismo , Membrana Dobles de Lípidos/metabolismo , Transporte Biológico , Radioisótopos de Carbono , Concentración de Iones de Hidrógeno , Cinética , Ácido Palmítico/metabolismo , PermeabilidadRESUMEN
Incorporation and oxidation of fatty acids (FA) were investigated in resident and thioglycolate-elicited (TG-elicited) rat macrophages (Mphi). Both cell types presented a time-dependent incorporation of [14C]-labeled palmitic acid (PA), oleic acid (OA), linoleic acid (LA), and arachidonic acid (AA) up to 6 h. The total amount of [14C]-FA incorporated by resident Mphi after 6 h was: AA > PA = LA > OA. TG-elicited cells presented a 50% reduction in the incorporation of LA, PA, and AA, whereas that of OA remained unchanged as compared to resident Mphi. The FA were oxidized by resident Mphi as follows: LA > OA > PA > AA. TG elicitation promoted a reduction of 42% in LA oxidation and a marked increase in AA oxidation (280%). The increased oxidation of AA in TG-elicited cells may account for the lower production of prostaglandins in Mphi under these conditions. The full significance of these findings for Mphi function, however, remains to be examined.
Asunto(s)
Ácidos Grasos/metabolismo , Macrófagos Peritoneales/metabolismo , Tioglicolatos/farmacología , Animales , Ácido Araquidónico/metabolismo , Cinética , Ácido Linoleico/metabolismo , Macrófagos Peritoneales/efectos de los fármacos , Masculino , Ácido Oléico/metabolismo , Oxidación-Reducción , Ácido Palmítico/metabolismo , Ratas , Ratas WistarAsunto(s)
Ácidos Linoleicos/metabolismo , Linfocitos/fisiología , Macrófagos Peritoneales/fisiología , Ácido Oléico/metabolismo , Ácido Palmítico/metabolismo , Animales , Células Cultivadas , Técnicas de Cocultivo , Ácido Linoleico , Activación de Linfocitos , Linfocitos/efectos de los fármacos , Linfocitos/inmunología , Masculino , Ratas , Ratas Wistar , Tioglicolatos/farmacologíaRESUMEN
[14C]-labelled palmitic acid (PA), oleic acid (OA), linoleic (LA) and arachidonic (AA) acids were transferred from macrophages (M phi) to lymphocytes (LY) when equal numbers of the two cell types were co-cultured. The relative degree and amounts of the fatty acids transferred from M phi to LY are as follow: AA (368.57 +/- 21.62) = OA (274.52 +/- 15.41) > LA (42.11 +/- 8.31) = PA (36.53 +/- 2.45). The transfer units are nmol/10(10) M phi/10(10) LY and the values are mean +/- SEM for 7 experiments. The [14C]-radioactivity transferred was mainly directed to the phospholipid fraction of the lymphocytes (85% by PA, 86% by LA, 83% by OA and 79% by AA). In the same order as above, phosphatidylcholine was the phospholipid moiety most heavily labelled (82% by PA, 71% by LA, 66% by OA and 47% by AA). The amount of [14C]-radioactivity transferred to stimulated lymphocytes of thioglycollate treated animals remained unchanged for LA, PA and AA but reduced for OA (71%). The significance of these observations for the immune functions of the cells and resolution of the question of whether some of the [14C]-isotope transfer involves a component of exchange or is unequivocally net fatty acid mass transfer are still being investigated.
Asunto(s)
Ácidos Grasos/metabolismo , Linfocitos/metabolismo , Macrófagos/metabolismo , Animales , Transporte Biológico , Radioisótopos de Carbono/metabolismo , Separación Celular , Células Cultivadas , Centrifugación Isopicnica , Técnicas de Cocultivo , Masculino , Fosfolípidos/aislamiento & purificación , Ratas , Ratas Wistar , Tioglicolatos/farmacologíaRESUMEN
Since acetyl-CoA produced through pyruvate dehydrogenase reaction is poorly oxidized by the Krebs cycle in rat lymphocytes, the fate of acetyl units was investigated in these cells. The results presented here show that 24-h cultured lymphocytes actively synthesize lipids from [3-14C]pyruvate. Furthermore, a considerable amount of these lipids have shown to be exported into the culture medium. Experiments with [1-14C] acetate as a lipid precursor showed a close similarity with the rates of incorporation of [3-14C] pyruvate into the same lipid fractions. Treatment of lymphocytes with the mitogen concanavalin A (Con A) markedly enhanced [1-14C] acetate incorporation into a variety of lipids, but the lectin did not affect [3-14C] pyruvate incorporation. The results suggest that lymphocytes convert pyruvate into lipids via the acetyl-CoA pathway and that Con A interferes in lymphocyte lipogenesis but does not seem to affect the pyruvate dehydrogenase reaction. The ability to incorporate pyruvate into certain lipids may have an important role for the rapidly dividing capacity of lymphocytes since the human cancer strain HeLa 155 (a quickly proliferating cell line) also exhibits this feature by converting much more [3-14C] pyruvate into lipids than do lymphocytes. In addition, comparative experiments with lymphocytes, peritoneal macrophages and HeLa cells indicate that pyruvate may provide precursors for cells with active lipid producing and exporting capacities.